B2M and cancer: The study identified a cancer cell subtype tS2 that deviated from the normal differentiation trajectory and dominated metastasis, revealing that remodeling of tumor-derived vascular endothelial cell subsets reduced antigen presentation (including B2M) and immune cell homing activity, providing new insights into understanding cellular behavior and tumor immune escape mechanisms in lung cancer TME.